Friday, 19. December 2025 Share: Earnings 18. December 2025 15:28 A new generation of weight-loss drugs is getting closer to patients. Here’s how they differ from Wegovy and Zepbound. Eli Lilly and Novo Nordisk file their new weight-loss drugs with the FDA. Source: MarketWatch Continue reading...
Earnings Why Eli Lilly shares should be higher — plus, our wishlist for Nike's earnings 18. December 2025
Earnings The next year will be for stock picking — and the next two weeks should see gains, says Goldman Sachs 18. December 2025
Earnings It’s time to take profits in silver after record-breaking run, these analysts say 18. December 2025